A citation-based method for searching scientific literature

Katherine E Tansey, Michel Guipponi, Xiaolan Hu, Enrico Domenici, Glyn Lewis, Alain Malafosse, Jens R Wendland, Cathryn M Lewis, Peter McGuffin, Rudolf Uher. Biol Psychiatry 2013
Times Cited: 130







List of co-cited articles
785 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
30

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
526
30


Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Saiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca-García, Eduard Vieta, José M Olivares,[...]. BMC Psychiatry 2017
105
26


Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
Rudolf Uher, Nader Perroud, Mandy Y M Ng, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery,[...]. Am J Psychiatry 2010
254
22

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
290
22

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
Daniel K Hall-Flavin, Joel G Winner, Josiah D Allen, Joseph M Carhart, Brian Proctor, Karen A Snyder, Maureen S Drews, Linda L Eisterhold, Jennifer Geske, David A Mrazek. Pharmacogenet Genomics 2013
131
21

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
21

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Josiah D Allen, Bryan M Dechairo. Discov Med 2013
119
20

Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.
Paul Bradley, Michael Shiekh, Vishaal Mehra, Keith Vrbicky, Stacey Layle, Marilyn C Olson, Alejandra Maciel, Ali Cullors, Jorge A Garces, Andrew A Lukowiak. J Psychiatr Res 2018
91
21

Commercial pharmacogenetic-based decision-support tools in psychiatry.
Chad A Bousman, Malcolm Hopwood. Lancet Psychiatry 2016
79
24

Pharmacogenetics in major depression: a comprehensive meta-analysis.
Tomihisa Niitsu, Chiara Fabbri, Francesco Bentini, Alessandro Serretti. Prog Neuropsychopharmacol Biol Psychiatry 2013
140
18

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.
J M Biernacka, K Sangkuhl, G Jenkins, R M Whaley, P Barman, A Batzler, R B Altman, V Arolt, J Brockmöller, C H Chen,[...]. Transl Psychiatry 2015
76
23

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
16

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
Marcus Ising, Susanne Lucae, Elisabeth B Binder, Thomas Bettecken, Manfred Uhr, Stephan Ripke, Martin A Kohli, Johannes M Hennings, Sonja Horstmann, Stefan Kloiber,[...]. Arch Gen Psychiatry 2009
225
15

A genomewide association study of citalopram response in major depressive disorder.
Holly A Garriock, Jeffrey B Kraft, Stanley I Shyn, Eric J Peters, Jennifer S Yokoyama, Gregory D Jenkins, Megan S Reinalda, Susan L Slager, Patrick J McGrath, Steven P Hamilton. Biol Psychiatry 2010
220
15

Pharmacogenetics of antidepressant response: A polygenic approach.
Judit García-González, Katherine E Tansey, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery, Tina Žagar,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2017
51
29

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
John F Greden, Sagar V Parikh, Anthony J Rothschild, Michael E Thase, Boadie W Dunlop, Charles DeBattista, Charles R Conway, Brent P Forester, Francis M Mondimore, Richard C Shelton,[...]. J Psychiatr Res 2019
122
15

Using a pharmacogenomic algorithm to guide the treatment of depression.
D K Hall-Flavin, J G Winner, J D Allen, J J Jordan, R S Nesheim, K A Snyder, M S Drews, L L Eisterhold, J M Biernacka, D A Mrazek. Transl Psychiatry 2012
128
14

Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Chad A Bousman, Katarina Arandjelovic, Serafino G Mancuso, Harris A Eyre, Boadie W Dunlop. Pharmacogenomics 2019
85
16

Switching antidepressant class does not improve response or remission in treatment-resistant depression.
Daniel Souery, Alessandro Serretti, Raffaella Calati, Pierre Oswald, Isabelle Massat, Anastasios Konstantinidis, Sylvie Linotte, Joseph Bollen, Koen Demyttenaere, Siegfried Kasper,[...]. J Clin Psychopharmacol 2011
63
20



Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Seth Goldfarb, Josiah D Allen, Gabriela Lavezzari, Kelly K Parsons, Andrew G Marshak, Susan Garavaglia, Bryan M Dechairo. Curr Med Res Opin 2015
62
19

A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
12

Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
Raquel Iniesta, Karim Malki, Wolfgang Maier, Marcella Rietschel, Ole Mors, Joanna Hauser, Neven Henigsberg, Mojca Zvezdana Dernovsek, Daniel Souery, Daniel Stahl,[...]. J Psychiatr Res 2016
83
14

Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.
Zane Zeier, Linda L Carpenter, Ned H Kalin, Carolyn I Rodriguez, William M McDonald, Alik S Widge, Charles B Nemeroff. Am J Psychiatry 2018
74
16

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.
J Winner, J D Allen, C Anthony Altar, A Spahic-Mihajlovic. Transl Psychiatry 2013
93
11

A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders.
Francis X Brennan, Kathryn R Gardner, Jay Lombard, Roy H Perlis, Maurizio Fava, Herbert W Harris, Rachel Scott. Prim Care Companion CNS Disord 2015
30
36


The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
Barbara Breitenstein, Sandra Scheuer, Hildegard Pfister, Manfred Uhr, Susanne Lucae, Florian Holsboer, Marcus Ising, Tanja M Brückl. CNS Spectr 2014
35
31

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
Naomi R Wray, Stephan Ripke, Manuel Mattheisen, Maciej Trzaskowski, Enda M Byrne, Abdel Abdellaoui, Mark J Adams, Esben Agerbo, Tracy M Air, Till M F Andlauer,[...]. Nat Genet 2018
11

Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
Chiara Fabbri, Joseph Zohar, Alessandro Serretti. Prog Neuropsychopharmacol Biol Psychiatry 2018
28
39


Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.
Katherine E Tansey, Michel Guipponi, Nader Perroud, Guido Bondolfi, Enrico Domenici, David Evans, Stephanie K Hall, Joanna Hauser, Neven Henigsberg, Xiaolan Hu,[...]. PLoS Med 2012
84
11


Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
C A Altar, J M Carhart, J D Allen, D K Hall-Flavin, B M Dechairo, J G Winner. Pharmacogenomics J 2015
67
14

Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.
Kimberly Peterson, Eric Dieperink, Johanna Anderson, Erin Boundy, Lauren Ferguson, Mark Helfand. Psychopharmacology (Berl) 2017
34
29

Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies.
C Anthony Altar, Joseph Carhart, Josiah D Allen, Daniel Hall-Flavin, Joel Winner, Bryan Dechairo. Mol Neuropsychiatry 2015
43
23

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
A John Rush, Maurizio Fava, Stephen R Wisniewski, Philip W Lavori, Madhukar H Trivedi, Harold A Sackeim, Michael E Thase, Andrew A Nierenberg, Frederic M Quitkin, T Michael Kashner,[...]. Control Clin Trials 2004
665
10

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.
Alexander Kautzky, Pia Baldinger, Daniel Souery, Stuart Montgomery, Julien Mendlewicz, Joseph Zohar, Alessandro Serretti, Rupert Lanzenberger, Siegfried Kasper. Eur Neuropsychopharmacol 2015
56
17


Cross-trial prediction of treatment outcome in depression: a machine learning approach.
Adam Mourad Chekroud, Ryan Joseph Zotti, Zarrar Shehzad, Ralitza Gueorguieva, Marcia K Johnson, Madhukar H Trivedi, Tyrone D Cannon, John Harrison Krystal, Philip Robert Corlett. Lancet Psychiatry 2016
295
9

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
651
9


A mega-analysis of genome-wide association studies for major depressive disorder.
Stephan Ripke, Naomi R Wray, Cathryn M Lewis, Steven P Hamilton, Myrna M Weissman, Gerome Breen, Enda M Byrne, Douglas H R Blackwood, Dorret I Boomsma, Sven Cichon,[...]. Mol Psychiatry 2013
770
8


PLINK: a tool set for whole-genome association and population-based linkage analyses.
Shaun Purcell, Benjamin Neale, Kathe Todd-Brown, Lori Thomas, Manuel A R Ferreira, David Bender, Julian Maller, Pamela Sklar, Paul I W de Bakker, Mark J Daly,[...]. Am J Hum Genet 2007
8

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy.
Stefano Porcelli, Chiara Fabbri, Alessandro Serretti. Eur Neuropsychopharmacol 2012
209
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.